Article
Challenges and Considerations on Risk-Reducing Surgery in BRCA1/2 Patients with Advanced Breast Cancer.
Current oncology (Toronto, Ont.) - 14 Jan 2021
Vasconcelos de Matos Leonor, Fernandes Leonor, Louro Pedro, Plácido Ana, Barros Manuel, Vaz Fátima
Abstract excerpt
Cancer survivors harboring inherited pathogenic variants in the breast cancer (BC) susceptibility genes BRCA1 or BRCA2 are at increased risk of ovarian cancer (OC) and also of contralateral BC. For these women, risk-reducing surgery (RRS) may contribute to risk management. However, women with locally advanced or metastatic breast cancer (ABC) were excluded from clinical trials evaluating the benefit of these...
Topics
- BRCA1 Protein
- Breast Neoplasms
- Female
- Genes, BRCA1
- Genes, BRCA2
- Heterozygote
- Humans
- Mutation
